Call for Proposal: Seed Grant Program for Cardiovascular Nanomedicine-Due October 1
Emory University/Georgia Tech was recently awarded a Program of Excellence in Nanotechnology (PEN) by the NIH/NHLBI, and established the Center for Translational Cardiovascular Nanomedicine (CTCN). The broad and long-term vision of the CTCN is to develop and apply nanotechnology and biomolecular engineering tools and approaches to address the compelling medical needs in the detection and treatment of atherosclerosis and the repair of damaged vasculature and heart tissue.
To help achieve the goals of the CTCN, explore new ideas in cardiovascular nanomedicine, and facilitate the development of new collaborations between Georgia Tech and Emory University in cardiology and molecular imaging, with support from Georgia Tech College of Engineering and Emory University School of Medicine, a seed grant program associated with the CTCN has been established.
All faculty members at Georgia Tech and Emory are welcome to submitproposal(s) to this seed grant program. However, the following requirements must be met: (1) The proposed research should be consistent with the vision and goals of the CTCN; (2) two investigators, one from Georgia Tech and the other from Emory, should serve as co-PIs of the proposed project; (3) the proposed research project should have a high probability of receiving NIH funding for subsequent studies.
Send questions to amy.tang@bme.gatech.edu.